Literature DB >> 11530242

Differential expression of metallothioneins in the CNS of mice with experimental autoimmune encephalomyelitis.

C Espejo1, J Carrasco, J Hidalgo, M Penkowa, A Garcia, I Sáez-Torres, E M Martínez-Cáceres.   

Abstract

Multiple sclerosis is an inflammatory, demyelinating disease of the CNS. Metallothioneins-I+II are antioxidant proteins induced in the CNS by immobilisation stress, trauma or degenerative diseases which have been postulated to play a neuroprotective role, while the CNS isoform metallothionein-III has been related to Alzheimer's disease. We have analysed metallothioneins-I-III expression in the CNS of mice with experimental autoimmune encephalomyelitis. Moreover, we have examined the putative role of interferon-gamma, a pro-inflammatory cytokine, in the control of metallothioneins expression during experimental autoimmune encephalomyelitis in interferon-gamma receptor knockout mice with two different genetic backgrounds: 129/Sv and C57BL/6x129/Sv. Mice with experimental autoimmune encephalomyelitis showed a significant induction of metallothioneins-I+II in the spinal cord white matter, and to a lower extent in the brain. Interferon-gamma receptor knockout mice suffered from a more severe experimental autoimmune encephalomyelitis, and interestingly showed a higher metallothioneins-I+II induction in both white and grey matter of the spinal cord and in the brain. In contrast to the metallothioneins-I+II isoforms, metallothionein-III expression remained essentially unaltered during experimental autoimmune encephalomyelitis; interferon-gamma receptor knockout mice showed an altered metallothionein-III expression (a slight increase in the spinal cord white matter) only in the C57BL/6x129/Sv background. Metallothioneins-I+II proteins were prominent in areas of induced cellular infiltrates. Reactive astrocytes and activated monocytes/macrophages were the sources of metallothioneins-I+II proteins. From these results we suggest that metallothioneins-I+II but not metallothionein-III may play an important role during experimental autoimmune encephalomyelitis, and indicate that the pro-inflammatory cytokine interferon-gamma is unlikely an important factor in this response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11530242     DOI: 10.1016/s0306-4522(01)00252-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

Review 1.  Metallothionein and brain inflammation.

Authors:  Yasmina Manso; Paul A Adlard; Javier Carrasco; Milan Vašák; Juan Hidalgo
Journal:  J Biol Inorg Chem       Date:  2011-06-16       Impact factor: 3.358

Review 2.  Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis.

Authors:  Lisa K Peterson; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2006-12-28       Impact factor: 3.478

3.  Lack of association between autism and four heavy metal regulatory genes.

Authors:  Sarah E Owens; Marshall L Summar; Kelli K Ryckman; Jonathan L Haines; Sara Reiss; Samantha R Summar; Michael Aschner
Journal:  Neurotoxicology       Date:  2011-07-20       Impact factor: 4.294

4.  Metallothioneins and brain injury: What transgenic mice tell us.

Authors:  Juan Hidalgo
Journal:  Environ Health Prev Med       Date:  2004-05       Impact factor: 3.674

5.  Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis.

Authors:  Ana Gutiérrez-Franco; Herena Eixarch; Carme Costa; Vanessa Gil; Mireia Castillo; Laura Calvo-Barreiro; Xavier Montalban; José A Del Río; Carmen Espejo
Journal:  Mol Neurobiol       Date:  2016-10-06       Impact factor: 5.590

6.  Tolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen.

Authors:  Herena Eixarch; Carmen Espejo; Alba Gómez; María José Mansilla; Mireia Castillo; Alexander Mildner; Francisco Vidal; Ramón Gimeno; Marco Prinz; Xavier Montalban; Jordi Barquinero
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

7.  Anti-myelin antibodies play an important role in the susceptibility to develop proteolipid protein-induced experimental autoimmune encephalomyelitis.

Authors:  N Marín; H Eixarch; M J Mansilla; E Rodríguez-Martín; M Mecha; C Guaza; J C Álvarez-Cermeño; X Montalban; L M Villar; C Espejo
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

8.  Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.

Authors:  Marta Miralles; Herena Eixarch; Marcos Tejero; Carme Costa; Keiji Hirota; A Raul Castaño; Meritxell Puig; Gitta Stockinger; Xavier Montalban; Assumpció Bosch; Carmen Espejo; Miguel Chillon
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 9.  Metallothioneins: Emerging Modulators in Immunity and Infection.

Authors:  Kavitha Subramanian Vignesh; George S Deepe
Journal:  Int J Mol Sci       Date:  2017-10-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.